Black-Musli Extract Boosts Testosterone in Rats, Study Suggests
Cepham has shared soon-to-be-published study results that suggest its BlaMus black-musli extract may be an effective testosterone booster.
Photo © iStockphoto.com/monkeybusinessimages
Cepham Inc. (Piscataway, NJ) has shared new, soon-to-be-published study results that suggest its black-musli extract (Curculigo orchioides), BlaMus, may help boost testosterone levels in rats.
The study included 24 male Wistar rats that weighed 200–230 g at baseline and were housed in optimal laboratory conditions. For 28 days, the rats were randomized to one of four treatment groups, receiving oral administrations of BlaMus of either 0 mg/kg of body weight, 10 mg/kg of body weight, 25 mg/kg of body weight, or 50 mg/kg of body weight. Researchers monitored rat body weight, free testosterone levels in serum, serum total testosterone levels, liver function based on SGOT and SGPT levels, and kidney function based on serum creatinine and blood urea nitrogen (BUN) levels.
While no marked elevation in serum free testosterone levels was found in the 10-mg or 25-mg BlaMus groups, the 50-mg group showed a significant increase in serum free testosterone levels after 28 days of supplementation, Cepham reports. Serum total testosterone levels, on the other hand, did not show significant increases in any of the studied groups.
Another positive sign came from histopathological analyses, including assessments of the rat seminiferous tubules, spermatogenesis, sperm-cell morphology, Leydig cells, and Sertoli cells, which revealed BlaMus dose–dependent improvements in the structural integrity of these features, according to Cepham.
“These data demonstrated that BlaMus may serve as a safe and novel natural testosterone booster, and provide broad-spectrum applications in sports nutrition, muscle building, and exercise pathophysiology,” researchers concluded. The study also found there were no significant changes observed for serum SGOT, SGPY, BUN, or creatinine kinase levels in any treatment group, so the results also support the safety of BlaMus.
Debasis Bagchi, PhD, chief scientific officer for Cepham and one author of the study, told Nutritional Outlook that the study results will be presented at the upcoming Experimental Biology 2017 meeting in Chicago, and Cepham plans to submit the study manuscript for peer-reviewed publication this April.
Read more:
Protecting the Fellows: Dietary Supplements for Prostate Health
Sexy Supplements: Botanical Ingredients for Sex Health
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
